Sara van den Berg

129 5 Hallmarks of CMV-specific T-cells 50. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood. 2004;104(12):3664-71. 51. Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J, et al. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity. Blood. 2011;118(12):3301-10. 52. Almehmadi M, Hammad A, Heyworth S, Moberly J, Middleton D, Hopkins MJ, et al. CD56+ T-cells are increased in kidney transplant patients following cytomegalovirus infection. Transpl Infect Dis. 2015;17(4):518-26. 53. Kared H, Martelli S, Ng TP, Pender SL, Larbi A. CD57 in human natural killer cells and T-lymphocytes. Cancer Immunol Immunother. 2016;65(4):441-52. 54. Northfield J, Lucas M, Jones H, Young NT, Klenerman P. Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD8 T-cells correlates with ‘memory inflation’ in human cytomegalovirus infection. Immunol Cell Biol. 2005;83(2):182-8. 55. Hoji A, Connolly NC, Buchanan WG, Rinaldo CR, Jr. CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T-cells. Clin Vaccine Immunol. 2007;14(1):74-80. 56. Gordon CL, Lee LN, Swadling L, Hutchings C, Zinser M, Highton AJ, et al. Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8(+) T-cells by Persistent Viruses and Vaccines. Cell Rep. 2018;23(3):768-82. 57. van de Berg PJ, Yong SL, Remmerswaal EB, van Lier RA, ten Berge IJ. Cytomegalovirus-induced effector T-cells cause endothelial cell damage. Clin Vaccine Immunol. 2012;19(5):772-9. 58. Bottcher JP, Beyer M, Meissner F, Abdullah Z, Sander J, Hochst B, et al. Functional classification of memory CD8(+) T-cells by CX3CR1 expression. Nat Commun. 2015;6:8306. 59. Lang KS, Moris A, Gouttefangeas C, Walter S, Teichgraber V, Miller M, et al. High frequency of human cytomegalovirus (HCMV)-specific CD8+ T-cells detected in a healthy CMV-seropositive donor. Cell Mol Life Sci. 2002;59(6):1076-80. 60. van Aalderen MC, Remmerswaal EB, Verstegen NJ, Hombrink P, ten Brinke A, Pircher H, et al. Infection history determines the differentiation state of human CD8+ T-cells. J Virol. 2015;89(9):5110- 23. 61. Vieira Braga FA, Hertoghs KM, Kragten NA, Doody GM, Barnes NA, Remmerswaal EB, et al. Blimp-1 homolog Hobit identifies effector-type lymphocytes in humans. Eur J Immunol. 2015;45(10):2945- 58. 62. Kragten NAM, Behr FM, Vieira Braga FA, Remmerswaal EBM, Wesselink TH, Oja AE, et al. Blimp-1 induces and Hobit maintains the cytotoxic mediator granzyme B in CD8 T-cells. Eur J Immunol. 2018;48(10):1644-62. 63. Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB. Four distinct patterns of memory CD8 T-cell responses to chronic murine cytomegalovirus infection. J Immunol. 2006;177(1):450-8. 64. Jackson SE, Mason GM, Okecha G, Sissons JG, Wills MR. Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T-cells. J Virol. 2014;88(18):10894-908. 65. Marchi E, Lee LN, Klenerman P. Inflation vs. Exhaustion of Antiviral CD8+ T-Cell Populations in Persistent Infections: Two Sides of the Same Coin? Front Immunol. 2019;10(197). 66. Sierro S, Rothkopf R, Klenerman P. Evolution of diverse antiviral CD8+ T-cell populations after murine cytomegalovirus infection. Eur J Immunol. 2005;35(4):1113-23. 67. Sauce D, Larsen M, Curnow SJ, Leese AM, Moss PA, Hislop AD, et al. EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15. Blood. 2006;108(1):11-8.